Oxygen therapy in chronic obstructive pulmonary disease.

Since the introduction of oxygen as a therapeutic agent 70 years ago, much has been learned regarding the detrimental effects of hypoxemia and the beneficial impact of oxygen therapy. It is projected that there are close to 800,000 patients receiving long-term oxygen therapy (LTOT) in the United States, at a cost of approximately $1.8 billion annually. The large numbers of patients receiving supplemental oxygen as treatment and the high costs incurred in providing oxygen therapy necessitate the practitioner to know the indications for LTOT as well its effects on survival, pulmonary hemodynamics, sleep, and exercise capacity. It is now recognized that the basis for LTOT prescription for all patients is founded on data that are over 25 years old and that only involve a very select cohort of patients. It is clear that further studies are required to assess the effects of oxygen on patients with chronic obstructive pulmonary disease with only mild hypoxemia, not only survival but also on neurocognitive function, quality of life, exercise physiology, and sleep quality. In addition, although proven to be safe when prescribed long term to individuals with lung disease, there are some concerns about worsening carbon dioxide retention and increased oxidant injury. The goals of this article are to briefly describe the indications for chronic oxygen administration, the physiologic effects of treatment, and potential toxicities, as well as its effect on morbidity and mortality.

[1]  H. Manning,et al.  Pathophysiology of dyspnea. , 1995, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[2]  Y. Phillips,et al.  The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure. , 1995, Chest.

[3]  R. Casaburi,et al.  Recommendations of the Fifth Oxygen Consensus Conference. Writing and Organizing Committees. , 2000, Respiratory care.

[4]  D. Górecka,et al.  Acute effect of oxygen on pulmonary arterial pressure does not predict survival on long-term oxygen therapy in patients with chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[5]  L. Heunks,et al.  Supplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[6]  P. Corris,et al.  Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. , 1991, The American review of respiratory disease.

[7]  D. Górecka,et al.  Psychological status of COPD patients before and after one year of long-term oxygen therapy. , 1996, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[8]  A. J. Block,et al.  Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). , 1979, The American journal of medicine.

[9]  W. O'Donohue,et al.  Magnitude of usage and cost of home oxygen therapy in the United States. , 1995, Chest.

[10]  F. Khaja,et al.  Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. , 1985, Annals of internal medicine.

[11]  A. Chaouat,et al.  A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. , 1999, The European respiratory journal.

[12]  R. Klocke,et al.  Detection and correction of hypoxemia associated with air travel. , 1993, The American review of respiratory disease.

[13]  J. Garrett,et al.  Long-term oxygen therapy improves health-related quality of life. , 2004, Respiratory medicine.

[14]  N. Douglas,et al.  The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. , 1982, The American review of respiratory disease.

[15]  M. Fournier,et al.  Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[16]  Robert Wise,et al.  Predictors of mortality in patients with emphysema and severe airflow obstruction. , 2006, American journal of respiratory and critical care medicine.

[17]  L. Mantell,et al.  Signal transduction pathways in hyperoxia-induced lung cell death. , 2000, Molecular genetics and metabolism.

[18]  M. Phillips,et al.  Effect of oxygen on breath markers of oxidative stress , 2003, European Respiratory Journal.

[19]  N. Saunders,et al.  Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. , 1986, Thorax.

[20]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[21]  A. Braghiroli,et al.  Sleep-related oxygen desaturation and daytime pulmonary haemodynamics in COPD patients. , 1992, The European respiratory journal.

[22]  P. Barnes,et al.  Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation , 2004, Thorax.

[23]  D. O’Donnell,et al.  Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[24]  E. Fletcher,et al.  Survival in COPD Patients with a Daytime PaO2 >60 mm Hg with and without Nocturnal Oxyhemoglobin Desaturation , 1992 .

[25]  N. Dean,et al.  Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. , 1992, The American review of respiratory disease.

[26]  T. Petty,et al.  Long-term continuous oxygen therapy in chronic airway obstruction. Mortality in relationship to cor pulmonale, hypoxia, and hypercapnia. , 1970, Annals of internal medicine.

[27]  D. Sax,et al.  Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. , 1975, The American journal of medicine.

[28]  J G Martin,et al.  Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. , 1985, The American review of respiratory disease.

[29]  L. Adams,et al.  Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. , 1987, Clinical science.

[30]  S. M. Lee,et al.  Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. , 2001, The European respiratory journal.

[31]  G. Criner,et al.  Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia. , 1987, Journal of applied physiology.

[32]  Y. Donati,et al.  Oxygen toxicity in mouse lung: pathways to cell death. , 1998, American journal of respiratory cell and molecular biology.

[33]  D. Caillaud,et al.  Oxygen toxicity: simultaneous measure of pentane and malondialdehyde in humans exposed to hyperoxia. , 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  S. Ward,et al.  Assessment of oxygen supplementation during air travel. , 1996, Thorax.

[35]  A. Loiseau,et al.  Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. , 1979, Chest.

[36]  S. Quan,et al.  The relation of sleep complaints to respiratory symptoms in a general population. , 1994, Chest.

[37]  J. Fleetham,et al.  Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. , 1982, The American review of respiratory disease.

[38]  C. Fletcher,et al.  Serial studies of 100 patients with chronic airway obstruction in London and Chicago , 1967, Thorax.

[39]  G H Guyatt,et al.  Oxygen therapy during exercise training in chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.

[40]  D. Morrison,et al.  Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. , 1992, Chest.

[41]  M. Aubier,et al.  Effects of the Administration of O2 on Ventilation and Blood Gases in Patients with Chronic Obstructive Pulmonary Disease During Acute Respiratory Failure1–3 , 2015 .

[42]  L. Adams,et al.  Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. , 1988, Clinical science.

[43]  E. Fletcher,et al.  A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. , 1992, The American review of respiratory disease.

[44]  I Grant,et al.  Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. , 1983, Archives of internal medicine.

[45]  M. Vízek,et al.  HYPOXIA AND REOXYGENATION INCREASE H 2 O 2 PRODUCTION IN RATS , 2003, Experimental lung research.

[46]  G. Divine,et al.  Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mm Hg. , 1987, Chest.

[47]  G. Criner.  Effects of long-term oxygen therapy on mortality and morbidity. , 2000, Respiratory care.

[48]  E. Weitzenblum,et al.  Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.